Skip to content

Clinical Study on the Effect of Blueberry Anthocyanins Combined with Prebiotics on Frailty in Elderly Patients with Cardiovascular Disease

Clinical Study on the Effect of Blueberry Anthocyanins Combined with Prebiotics on Frailty in Elderly Patients with Cardiovascular Disease - Blueberry anthocyanins combined with prebiotics improve frailty in elderly patients with cardiovascular disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096215
Enrollment
Unknown
Registered
2025-01-20
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty

Interventions

Pre-frailty group :The first 64 subjects were assigned to the treatment group (blueberry anthocyanins combined with prebiotics), while the latter 4 subjects were assigned to the placebo group (maltode
Frailty group :The first 64 subjects were assigned to the treatment group (blueberry anthocyanins combined with prebiotics), while the latter 4 subjects were assigned to the placebo group (maltodextri

Sponsors

People's Hospital of Pidu District, Chengdu City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Part One: (1) Meets the diagnostic criteria related to cardiovascular disease and has been diagnosed through clinical examination and other tests; (2) Age >= 18 years old; (3) Individuals who are conscious and able to communicate normally; (4) Recognized research proposal and willing to participate in this survey Part 2: (1) Meets the diagnostic criteria related to cardiovascular disease and has undergone clinical examinations to meet the criteria for frailty; (2) Individuals who are conscious and able to communicate normally; (3) I acknowledge the research proposal and am willing to participate in this survey.

Exclusion criteria

Exclusion criteria: Part One: (1) Patients with malignant arrhythmia, grade III or above heart failure, cerebral hemorrhage, and aortic dissection (2) Dementia, severe cognitive impairment, mental illness, consciousness disorders, and inability to communicate; (3) Cancer or other serious diseases (cancer has recovered well after surgery, no distant metastasis has been found, and currently no chemotherapy has been performed) Radiotherapy, taking special medications, etc. may not be ruled out; (4) Blindness; (5) Acute infection; (6) Not cooperating with investigators. Part 2: (1) Suffering from acute and chronic inflammatory diseases of the intestine within 3 months; (2) Used antibiotics within one month; (3) Have used probiotics, prebiotics, or synbiotics within one month; (4) Have used laxatives or medications for treating diarrhea within one month; (5) Used proton pump inhibitors within one month; (6) Used gastrointestinal motility drugs within one month.

Design outcomes

Primary

MeasureTime frame
Grip strength;Walking pace;Weighted;Height;systolic pressure;diastolic pressure;

Countries

China

Contacts

Public ContactRuolin Zhang

People's Hospital of Pidu District, Chengdu City

312767651@qq.com+86 135 5132 3470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026